Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID19- Infection with SARS-CoV-2 Virus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06217211
What this trial is testing

Eficacia Ventilatoria y Remolacha

Who this might be right for
SARS CoV 2 InfectionMuscle DisorderFatigue
Hospital de Mataró 30
Not applicableActive Not RecruitingNCT05321407
What this trial is testing

COVID-19 Vaccine Responses in PIDD Subjects

Who this might be right for
X-linked AgammaglobulinemiaXLAPrimary Immune Deficiency+4 more
Duke University 100
Testing effectiveness (Phase 2)Ended earlyNCT05543707
What this trial is testing

PBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19

Who this might be right for
COVID-19
Pardes Biosciences, Inc. 242
Testing effectiveness (Phase 2)UnknownNCT04907331
What this trial is testing

Heterologous SARS-CoV-2 Vaccination With ChAdOx-1 and BNT162b2

Who this might be right for
SARS-CoV2 Infection
Medical University Innsbruck 3,000
Not applicableStudy completedNCT05705661
What this trial is testing

INFLUENCE OF HIGH FREQUENCY CHEST WALL OSCILLATION IN HOSPITALIZED PATIENTS WITH COVID-19

Who this might be right for
COVID-19
Cairo University 70
Not applicableStudy completedNCT05216588
What this trial is testing

Pre-exposure Prophylaxis of SARS-CoV-2 Infection (COVID-19) by Monoclonal Antibodies With Early Access Authorization in Immunocompromised Patients. A Prospective Cohort.

Who this might be right for
COVID-19Immunocompromised Host
ANRS, Emerging Infectious Diseases 149
Early research (Phase 1)WithdrawnNCT04574869
What this trial is testing

RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory Failure

Who this might be right for
Acute Lung InjuryALICOVID-19
ReAlta Life Sciences, Inc.
Not applicableActive Not RecruitingNCT07204366
What this trial is testing

Autoantibodies Against Type I Interferon in Patients Affected With Ph-negative Myeloproliferative Neoplasms (MPN-IFN Study)

Who this might be right for
Myeloproliferative DiseaseCOVID - 19
Fondazione IRCCS Policlinico San Matteo di Pavia 219
Large-scale testing (Phase 3)Study completedNCT05354024
What this trial is testing

Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine

Who this might be right for
Coronavirus InfectionsHealthy
Butantan Institute 4,400
Testing effectiveness (Phase 2)UnknownNCT04637828
What this trial is testing

Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection

Who this might be right for
COVID-19
Genoscience Pharma 178
Not applicableStudy completedNCT04797871
What this trial is testing

Resistance Training and Clinical Status in Patients With Post Discharge Symptoms After Covid-19

Who this might be right for
Covid19SARS-CoV2Fatigue Syndrome, Chronic+2 more
Universidad Pública de Navarra 100
Testing effectiveness (Phase 2)Study completedNCT04342650
What this trial is testing

Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection

Who this might be right for
COVID-19SARS-CoV InfectionSevere Acute Respiratory Syndrome (SARS) Pneumonia+1 more
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado 152
Not applicableStudy completedNCT06043882
What this trial is testing

Number of Participants Diagnosed With Sarcoidosis by Bronchoscopic Transbronchial Needle Aspiration After COVID- 2019 .

Who this might be right for
SarcoidosisCOVID-19
Ain Shams University 55
Large-scale testing (Phase 3)Ended earlyNCT04377620
What this trial is testing

Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)

Who this might be right for
COVID-19
Incyte Corporation 211
Large-scale testing (Phase 3)UnknownNCT04483960
What this trial is testing

Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial

Who this might be right for
SARS-CoV-2 Infection (COVID-19)
University of Melbourne 2,200
Not applicableStudy completedNCT05178225
What this trial is testing

Spa Rehabilitation, Antioxidant and Bioenergetic Supportive Treatment of Patients With Post-Covid-19 Syndrome

Who this might be right for
COVID-19 Respiratory Infection
Comenius University 51
Post-approval studies (Phase 4)UnknownNCT04316377
What this trial is testing

Norwegian Coronavirus Disease 2019 Study

Who this might be right for
Corona Virus Infection
University Hospital, Akershus 53
Not applicableUnknownNCT04937712
What this trial is testing

Analysis of SARS-CoV2 Urine Viral Particles and Association With Proximal Tubular Dysfunction

Who this might be right for
SARS-CoV2 InfectionProximal Tubule Dysfunction
Central Hospital, Nancy, France 34
Not applicableUnknownNCT04456075
What this trial is testing

Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19

Who this might be right for
SARS-CoV2COVID
Heidelberg University 100
Not applicableStudy completedNCT04365595
What this trial is testing

SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir)

Who this might be right for
SARS-CoV 2COVID
University of Zurich 58
Next Page